{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T13:49:04Z","timestamp":1776692944682,"version":"3.51.2"},"reference-count":27,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T00:00:00Z","timestamp":1531094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI 111451"],"award-info":[{"award-number":["AI 111451"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI 109925"],"award-info":[{"award-number":["AI 109925"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.vaccine.2018.06.053","type":"journal-article","created":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T22:59:51Z","timestamp":1531522791000},"page":"5097-5103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity"],"prefix":"10.1016","volume":"36","author":[{"given":"Yasuko","family":"Hatta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Boltz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Sarawar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamuk","family":"Bilsel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2018.06.053_b0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/595861","article-title":"Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004\u20132005 season to the 2006\u20132007 season","volume":"199","author":"Belongia","year":"2009","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2018.06.053_b0010","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/cid\/ciw635","article-title":"2014\u20132015 Influenza Vaccine Effectiveness in the United States by Vaccine Type","volume":"63","author":"Zimmerman","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.053_b0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJMp1714916","article-title":"Chasing Seasonal Influenza - The Need for a Universal Influenza Vaccine","volume":"378","author":"Paules","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2018.06.053_b0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/vaccines3020373","article-title":"Influenza vaccination strategies: comparing inactivated and live attenuated influenza vaccines","volume":"3","author":"Sridhar","year":"2015","journal-title":"Vaccines (Basel)"},{"issue":"27","key":"10.1016\/j.vaccine.2018.06.053_b0025","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1016\/j.vaccine.2009.03.088","article-title":"Comparison of the trivalent live attenuated vs. inactivated influenza vaccines among U.S. military service members","volume":"27","author":"Eick","year":"2009","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.vaccine.2018.06.053_b0030","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1056\/NEJMoa061850","article-title":"Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines","volume":"355","author":"Ohmit","year":"2006","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2018.06.053_b0035","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/jama.2009.265","article-title":"Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel","volume":"301","author":"Wang","year":"2009","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.vaccine.2018.06.053_b0040","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1056\/NEJMoa0808652","article-title":"Comparative efficacy of inactivated and live attenuated influenza vaccines","volume":"361","author":"Monto","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.06.053_b0045","unstructured":"Agency EM. Fluenz Assessment Report. London: 2011, p. 1\u201385."},{"issue":"42","key":"10.1016\/j.vaccine.2018.06.053_b0050","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1016\/j.vaccine.2016.08.061","article-title":"M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice","volume":"34","author":"Sarawar","year":"2016","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.vaccine.2018.06.053_b0055","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1016\/j.vaccine.2017.06.039","article-title":"M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza","volume":"35","author":"Hatta","year":"2017","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2018.06.053_b0060","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2165\/11206860-000000000-00000","article-title":"Live attenuated influenza vaccine (FluMist(R); Fluenz): a review of its use in the prevention of seasonal influenza in children and adults","volume":"71","author":"Carter","year":"2011","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.vaccine.2018.06.053_b0065","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1128\/JVI.00450-09","article-title":"Influenza A virus lacking M2 protein as a live attenuated vaccine","volume":"83","author":"Watanabe","year":"2009","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2018.06.053_b0070","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1128\/JVI.78.11.5576-5583.2004","article-title":"Influenza B virus requires BM2 protein for replication","volume":"78","author":"Hatta","year":"2004","journal-title":"J Virol"},{"issue":"16","key":"10.1016\/j.vaccine.2018.06.053_b0075","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","article-title":"Generation of influenza A viruses entirely from cloned cDNAs","volume":"96","author":"Neumann","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.vaccine.2018.06.053_b0080","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1128\/JVI.01899-07","article-title":"Novel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants","volume":"82","author":"Watanabe","year":"2008","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.053_b0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2018.06.053_b0090","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/infdis\/jix526","article-title":"Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015\u20132016 Season in Canada","volume":"216","author":"Skowronski","year":"2017","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2018.06.053_b0095","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/cid\/ciu680","article-title":"Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons","volume":"59","author":"McLean","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2018.06.053_b0100","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/cid\/cit736","article-title":"Influenza vaccine effectiveness in the 2011\u20132012 season: protection against each circulating virus and the effect of prior vaccination on estimates","volume":"58","author":"Ohmit","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.053_b0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0042-6822(02)00035-1","article-title":"Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A\/Ann Arbor\/6\/60","volume":"306","author":"Jin","year":"2003","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2018.06.053_b0110","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1128\/iai.43.2.457-462.1984","article-title":"Relative immunogenicity of the cold-adapted influenza virus A\/Ann Arbor\/6\/60 (A\/AA\/6\/60-ca), recombinants of A\/AA\/6\/60-ca, and parental strains with similar surface antigens","volume":"43","author":"Tannock","year":"1984","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2018.06.053_b0115","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/08828240260066242","article-title":"Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines","volume":"15","author":"Murphy","year":"2002","journal-title":"Viral Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2018.06.053_b0120","doi-asserted-by":"crossref","first-page":"e2574","DOI":"10.1371\/journal.pone.0002574","article-title":"Baseline levels of influenza-specific CD4 memory T-cells affect T-cell responses to influenza vaccines","volume":"3","author":"He","year":"2008","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.053_b0125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/JVI.01957-06","article-title":"Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines","volume":"81","author":"Sasaki","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.06.053_b0130","first-page":"24(1)","article-title":"Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in Adults","author":"Hoft","year":"2017","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.053_b0135","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/infdis\/jis641","article-title":"Localized mucosal response to intranasal live attenuated influenza vaccine in adults","volume":"207","author":"Barria","year":"2013","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18308946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18308946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:27:16Z","timestamp":1759400836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18308946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":27,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0264410X18308946"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}